Quantcast

Morning Movers: Celgene Gains, Nike Drops, Valeant Rises


Stocks look set for a higher open this morning following recent selling pressure.

BP-AA457_swim_D_20170601172443.jpg Getty Images

S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have advanced 0.1%. Nasdaq Composite futures are little changed.

Celgene (CELG) has advanced 1.4% to $122.28 after getting upgraded to Outperform from Market Perform at Leerink.

Teva Pharmaceutical Industries (TEVA) has risen 1.8% to $30.98 after Mizuho raised its rating to Neutral from Underperform.

Booz Allen Hamilton (BAH) has tumbled 15% to $33.52 after reports that the DOJ is investigating its accounting. Vertical Research cut its rating to Hold from Buy, while Raymond James downgraded Booz Allen Hamilton to Market Perform from Outperform.

Kroger (KR) is has fallen 1.7% to $24.14 after getting cut to Neutral from Buy at Goldman Sachs, to Market Perform from Outperform at Telsey Advisory, and to Neutral from Overweight at JPMorgan one day after dropping 19% following a guidance cut.

Nike (NKE) has dropped 1.8% to $51.95 after getting cut to Neutral from Overweight at JPMorgan.

Valeant Pharmaceuticals International (VRX) has climbed 4.2% to $12.63 after Cantor Fitzgerald initiated coverage with an Overweight rating.

DuPont (DD) has risen 1% to $83.01 after its merger with Dow Chemical (DOW) was approved by the U.S. antitrust regulators. Dow Chemical has advanced 0.8% to $64.59.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , US Markets


More from Barron's

Subscribe






Barron's
Contributor:

Barron's









Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com